|
Getting your Trinity Audio player ready...
|
Palo Alto psychiatrist Rameen Ghorieshi joins Weekly journalists to discuss the potential of ketamine to treat severely depressed patients, who have seen remarkable results.
Watch the webcast here or listen to the podcast version of the episode here.
Timestamps for topics discussed on video:
To jump to a specific topic, open the description box below the video in YouTube and click on the timestamp.
• Background on ketamine (0:09)
• Esketamine, a ketamine nasal spray approved by the FDA (5:08
• Treatment process (9:03)
• Risks of ketamine (13:38)
• Future of ketamine (18:42)
Timestamps for topics discussed on podcast:
To jump to a specific topic, listen to the show on our podcast page and drag circle within the audio player’s progress bar to the desired timestamp.
• Background on ketamine (0:28)
• Esketamine, a ketamine nasal spray approved by the FDA (5:26)
• Treatment process (9:21)
• Risks of ketamine (13:55)
• Future of ketamine (18:59)
Subscribe to the new “Behind the Headlines” podcast
We now have a podcast! Listen to Behind the Headlines while you’re on the go by downloading free episodes of our new podcast, now available through Apple or Google Play.
Webcasts are posted every Friday afternoon on PaloAltoOnline.com, as well as on Palo Alto Online’s YouTube channel, youtube.com/paweekly.
Check out previous weeks’ episodes in the “Behind the Headlines” archive.